Barriers to warfarin use in atrial fibrillation

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1224, 2000-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Warfarin use suboptimal in new-onset atrial fibrillation

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 427, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Predictors of Warfarin Use in Atrial Fibrillation Patients in the Inpatient Setting

By Agarwal Shuchita  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 37-48

Adis International

Access to resources Recommend Favorite

Patterns and Predictors of Use of Warfarin and Other Common Long-Term Medications in Patients with Atrial Fibrillation

By Song Xue  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 4, 2012-08 ,pp. : 245-253

Adis International

Access to resources Recommend Favorite

Use of -Blockers in Atrial Fibrillation

By Kühlkamp V.   Bosch R.   Mewis C.   Seipel L.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 1, 2002-01 ,pp. : 37-42

Adis International

Access to resources Recommend Favorite

Anticoagulation Therapy for Patients with Non-Valvular Atrial Fibrillation: Comparison of Decision Analytic Model Recommendations and Real-World Warfarin Prescription Use

By Casciano Julian P.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 5, 2012-10 ,pp. : 313-323

Adis International

Access to resources Recommend Favorite